Category : Press

Category Archives: Press

Carlsbad, CA – Sure Genomics, Inc. reports it’s SureDNA service utilizes the FDA-cleared Oragene DX kit to collect saliva samples for sequencing the whole genome. Genetic testing requires the collection of high quality DNA samples. As a biological sample, saliva is easy to collect in the privacy of the home, quickly and painlessly. Oragene Dx has been cleared by the FDA for collection, stabilization and transportation of DNA from saliva for molecular diagnostics. Sure Genomics will mail an Oragene Dx saliva sampling kit once the genetic testing order has been authorized by a physician.

Sure Genomics is a personal genetics company dedicated to making personal DNA information accessible with unlimited DNA analysis over a person’s lifetime as new genetic discoveries are made. Sure Genomics platform helps people obtain and benefit from their full DNA sequence through a Get Look Plan™ system. Founded in 2013, Sure Genomics is located in Carlsbad, CA. Learn more at http://www.suregenomics.com and follow us on Twitter at @suregenomics.

Family Healthware™ Screens for Major Disease Risks Including Heart Disease, Stroke, Diabetes and Certain Cancers Based on Family History

Carlsbad, CA – Sure Genomics, Inc. today announces a partnership with Sanitas, Inc. to offer its Family Healthware application to consumers. Family Healthware is the only health risk assessment service with FDA 510(K) clearance for identifying a person’s familial risk for heart disease, stroke, diabetes, and colorectal, breast and ovarian cancers, and provides a personalized prevention plan to help reduce risk factors for these diseases.

“Sanitas is committed to helping people better understand their health risk factors which is a focus we share,” said Warren Little, co-founder and CEO of Sure Genomics. “Together we offer consumers and their healthcare providers reliable disease risk information, and can incorporate genetic information to help people make more informed decisions about their personal health.”

To create an overall health risk score, Family Healthware uses a quick, interactive questionnaire to collect health data, behaviors, recent lab tests and family medical history. Through the application, users can invite their relatives to participate, and keep a record of all information including family medical history, personal health information, and ancestry to reveal a more comprehensive family health history record which can be shared with their healthcare providers.

“Our companies saw a unique opportunity to deliver an integrated care experience to consumers built on both family health history and genetic insights,” said Naser Partovi, founder and CEO of Sanitas, Inc. “Our partnership will help enable consumers to become more activated in a truly personalized path for better health by understanding how family history and genetics can drive new insights for prevention and care.”

Sure Genomics’ SureDNA is the first personalized genomics service that uses the full DNA sequence to round out an individual’s proactive health portfolio. Consumers and their healthcare providers now have access to genetic information for life. The full genome sequence is stored in Sure Genomics’ SureVAULT™ so interpretations can be continually updated without further sample collection or laboratory testing. Because only a single test is required the time and cost savings over a lifetime becomes significant. Genetic testing requires a physician order, which can be provided by the individual’s healthcare provider or by a reference network of physicians.

Sure Genomics is a personal genetics company dedicated to making personal DNA information accessible with unlimited DNA analysis over a person’s lifetime as new genetic discoveries are made. Sure Genomics platform helps people obtain and benefit from their full DNA sequence through a Get Look Plan™ system. Founded in 2013, Sure Genomics is located in Carlsbad, CA. Learn more at http://www.suregenomics.com and follow us on Twitter at @suregenomics.

About Sanitas, Inc.

Founded in 2011 and headquartered in La Jolla, California, Sanitas is committed to helping health systems and provider practices achieve their care coordination goals that empower patients, boost outcomes, and reduce total care costs while keeping patients where they thrive best—at home. Sanitas is focused on enabling new models of value-based care to more efficiently and effectively identify risks and coordinate care to improve adherence to clinical care plans.

Carlsbad, CA – April 19, 2016 — Sure Genomics, Inc., a personal genetics company dedicated to making personal DNA information accessible, today announced Dr. Kenneth Ward, founder of the University of Utah’s DNA Diagnostic Laboratory and the Molecular Genetics Laboratory at ARUP, and former Professor of Obstetrics and Gynecology and Human Genetics at the University of Utah, has formally joined the company’s Advisory Board.

Internationally recognized for his research and work in the field of Medical Genetics, Dr. Ward is also a prominent high-risk pregnancy specialist. He is one of the only physicians in the United States who is board certified in four specialties including Obstetrics and Gynecology, Maternal-Fetal Medicine, Medical Genetics and Molecular Genetics.

“Dr. Ward’s 25 years of experience and research in DNA diagnostics has helped to revolutionize the field of medical diagnostics and high-risk pregnancy care,” said Warren Little, CEO and co-founder of Sure Genomics. “As a member of our advisory board, Ken will help expand our capabilities in keeping with new genetic discoveries.”

Dr. Ward is a board certified obstetrician/gynecologist with specialized training and certification in perinatology. He is one of the few OB-GYN physicians in the country who is also board certified in clinical genetics and molecular genetics. He established the University of Utah’s DNA Diagnostic Testing Laboratory in 1988 in connection with his research into the genetics of birth defects and obstetrical problems, and served as an Investigator for the Eccles Program in Human Molecular Biology and Genetics. After his residency in OB-GYN at George Washington University in 1987, he completed a fellowship in Maternal-Fetal Medicine and Medical Genetics at the University of Utah. Prior to devoting his full-time efforts to genetic research, Dr. Ward was Professor and Department Chair of the OB-GYN department at a major state university hospital and Medical School. He currently heads research at a major biotech company, and serves as Laboratory Director of the CLIA lab at Affiliated Genetics.

“Sure Genomics has created a new model for personal exploration and understanding of complex genomic information,” said Dr. Ward. “This excites me because greater understanding can help each of us mitigate some of our genetic challenges and amplify our strengths.”

Carlsbad, CA – Sure Genomics, Inc., a personal genetics company dedicated to making personal DNA information accessible, today announced Mark Yahiro, Intel’s Managing Director, New Business for the Perceptual Computing Group, has formally joined the company’s Advisory Board.

Yahiro leads Intel’s Perceptual Computing Group’s strategic business development team whose vision is to add senses and human-like interactions to drones, robotics, virtual reality and other new markets. Yahiro is an expert at defining and understanding product and technology trends, and creating opportunities that drive new revenue streams and build deeper customer relationships.

“Mark’s experience and understanding of emerging technologies along with his expertise and knowledge of interactive consumer-facing platforms makes him an ideal advisor,” said Warren Little, CEO and co-founder of Sure Genomics. “As a member of our advisory board, Mark will help guide our product interactions and business growth.”

“Sure Genomics has developed an elegant, consumer-friendly interface to complex personal genetic data,” said Yahiro. “I’m anticipating a wonderful reaction by the general public once this is launched.”

Mark Yahiro brings over 20 years experience in product planning and management, business development, and strategic partnerships and investments for both public and private companies including Intel, PureDepth, Pulse, Hitachi, and various start-ups. He received his MBA in International Business from DePaul University, earned his Software Engineering degree from the University of Illinois and attended the Art Institute of Chicago.

About Sure Genomics, Inc.

Sure Genomics is a personal genetics company dedicated to making personal DNA information accessible with unlimited DNA analysis over a person’s lifetime as new genetic discoveries are made. Sure Genomics platform helps people obtain and benefit from their full DNA sequence through a Get Look Plan™ system. Founded in 2013, Sure Genomics is located in Carlsbad, CA. Learn more at http://www.suregenomics.com and follow us on Twitter at @suregenomics.

Carlsbad, CA – March 15, 2016 — Sure Genomics, Inc., a personal genetics company dedicated to making personal DNA information accessible, today announced Dr. Doug Brutlag, Professor Emeritus of Biochemistry & Medicine at the Stanford University School of Medicine and Founder of The Brutlag Bioinformatics Group, has formally joined the company’s Advisory Board.

“Dr. Brutlag is a highly respected and accomplished individual whose research has greatly influenced our understanding of genomic information and the implications for medicine and biomedical research,” said Warren Little, CEO and co-founder of Sure Genomics. “We are excited to welcome Dr. Brutlag to our advisory board, and gain his insight and guidance as a pioneer for using computational means to understand biological data.”

Dr. Brutlag received his Ph.D. with Great Distinction from Stanford University in 1972 and has been a Professor of Biochemistry there since 1974. His research helped develop the field of bioinformatics, the application of computer science to molecular biology. In 1979 he was a co-founder of IntelliGenetics, one of the first firms involved in bioinformatics and in 1997 he co-founded the International Society for Computational Biology. He has served on the scientific advisory boards of many firms and organizations including the National Library of Medicine and the Max Planck Institute. Dr. Brutlag’s honors include an NIH Senior Fogarty Fellowship, Fellow of the American Association for the Advancement of Science, Fellow of the American College of Medical Informatics and Honorary Professor of Bioinformatics at Keio University, Japan. He was awarded the 1992 Computerworld-Smithsonian award in science.

“Sure Genomics is focused on delivering a personal genomics platform that excites me for its potential to allow exploration of one’s DNA information – not a simple task,” said Dr. Brutlag. “I look forward to helping guide the company and its leadership team towards that mission.”

About Sure Genomics, Inc.

Sure Genomics is a personal genetics company dedicated to making personal DNA information accessible with unlimited DNA analysis over a person’s lifetime as new genetic discoveries are made. Sure Genomics platform helps people obtain and benefit from their full DNA sequence through a Get Look Plan™ system. Founded in 2013, Sure Genomics is located in Carlsbad, CA. Learn more at http://www.suregenomics.com and follow us on Twitter at @suregenomics.

Platform Makes It Easy to Get, Look and Plan Proactive Health and Wellness Through the Lens of Personal DNA Information. Initial reports include BRCA1 and BRCA2, Drug Response and Interaction, Wellness, Traits and Ancestry.

Sure Genomics, Inc. today introduced the first at-home service to deliver a person’s full DNA sequence with a single saliva test — allowing for DNA comparisons to be reanalyzed and personal DNA information to be updated and reviewed over a person’s lifetime. This approach means comparisons can be generated as soon as new scientifically relevant information is made available relating to any of the more than 6 billion bases in the full DNA sequence.

The initial reports made available with physician oversight include BRCA1 and BRCA2 gene mutations, which indicate an increased risk of female breast and ovarian cancers, drug response and interaction, fitness and nutrition, traits and ancestry. Sure Genomics will release additional reports after they meet all required Food and Drug Administration (FDA) regulatory standards.

“Our company is dedicated to making personal DNA information accessible while providing an engaging platform to help foster deeper understanding of what our DNA says about ourselves,” said Warren Little, CEO and co-founder of Sure Genomics. “Just one test provides a lifetime of discoveries, helping us make more informed decisions about our personal health – and potentially our future generations.”

Making Sense of Your DNA: DNAman™ and DNAwoman™

For the first time, consumers will be able to access and engage with the information provided in a full DNA sequence. Users log in from any computer or mobile device to their secure portal on the Sure Genomics platform to explore and understand their DNA — through the lens of an interactive virtual body representation, identified as DNAman or DNAwoman, which focuses on their key genetic markers. Each of these markers is compared to the data sources maintained by National Institutes of Health (NIH) to create a DNA comparison of medical information, drug therapies, and potential interactions. As part of the service, the DNA comparison is automatically processed every six months providing dynamically updated information. Users can request automatic notifications when science discovers new markers in areas of interest, and have the option to expedite the comparisons, for a nominal fee, in advance of their semi-annual reanalysis. The platform makes it easy to extract any part of the results and share those results with third parties like a family member or healthcare professional.

How the Platform Works

Get a DNA Test: Users register online for a collection kit to mail-in a saliva sample – testing is physician prescribed and samples processed by a CLIA-certified lab. Full DNA sequencing ensures a higher degree of accuracy and the results can be reanalyzed continually against newly discovered markers without additional tests.

Look at Results: Sure Genomics bioinformaticians analyze the raw sequence data using information from public resources such as the NIH. It takes four weeks from receipt of collection kit for the analysis to be delivered on the platform, through which customers can view and explore their genetic characteristics, risks and tendencies.

Plan for Health and Wellness: Users can extract any part of their analysis and run custom reports to share with healthcare professionals. Because DNA is just one factor contributing to an individual’s health, the platform also stores family medical history, personal health information, and ancestry to reveal a more comprehensive picture. Automatic alerts are sent when new markers are identified, so users can learn about the latest discoveries in DNA and how they might relate to themselves.

“We worked closely with scientists and geneticists to design an interface that makes DNA analysis comprehension easier – for both users and physicians alike,” said Rick White, Chief Architect and co-founder of Sure Genomics. “Like navigation apps that apply data to circumvent traffic, we should be able to use our genetic code to navigate a course of action towards our ideal health and well-being. What we offer is more than just a DNA report; but a powerful wellness and education tool that helps us make holistic decisions to reach that goal.”

Leading technology and certifications:

Direct-to-consumer full DNA sequencing processed by a CLIA-certified lab

Analysis based on over 70,000 scientifically validated SNPs (bio-markers)

Privacy Commitment

Sure Genomics’ mission is to give everyone direct access to the information contained in their DNA, while protecting their privacy. The company will never sell or share personal information about its customers. Sure Genomics can assist customers who are interested in donating or selling their DNA data for science and research.

Price and Availability

Sure Genomics costs $2,500. The price includes full DNA sequencing by a CLIA-certified lab, HIPAA-compliant data storage, ongoing reports, DNA reanalysis every six months, and one-hour consultation with a trained genetics professional. After the first year a $150 annual subscription fee covers data storage and semi-annual DNA analysis against new and clinically validated markers.

The Sure Genomics kit is available for preorder starting today at www.suregenomics.com. The company expects to begin shipping kits by June 2016. The company is voiding the $150 annual subscription fee for the first 500 preorder customers for their lifetime.